Overview
What is Abigail Alliance For Better Access To Developmental Drugs Inc?
Abigail Alliance for Better Access to Developmental Drugs Inc. is a nonprofit organization that champions patient rights, specifically focusing on their access to developmental drugs. For the upcoming years, 2022 and 2023, the organization has revised its mission to prioritize initiatives related to cancer. The organization's efforts aim to advocate on behalf of patients, ensuring they have access to the medications they need. Their work in this field is crucial, contributing to the betterment of healthcare for individuals facing various health challenges.
Is Abigail Alliance For Better Access To Developmental Drugs Inc legitimate?
Abigail Alliance For Better Access To Developmental Drugs Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Abigail Alliance For Better Access To Developmental Drugs Inc submitted a form 990EZ, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
What is the mission statement of Abigail Alliance For Better Access To Developmental Drugs Inc?
Abigail Alliance for Better Access to Developmental Drugs, in its updated mission for 2022 and 2023, has shifted its focus towards advocating for cancer patients and their access to developmental drugs. The organization aims to champion the cause of these patients, ensuring they have access to the necessary medications. The primary objective is to drive improvements in cancer-related treatments and therapies. The Abigail Alliance continues to advocate on behalf of patients, working towards making developmental drugs more accessible. Their efforts are geared towards enhancing the lives of individuals battling cancer by providing them with the needed medical interventions.
Who is the CEO of Abigail Alliance For Better Access To Developmental Drugs Inc?
Prince Agarwal is the President of Abigail Alliance For Better Access To Developmental Drugs Inc.
What is the revenue of Abigail Alliance For Better Access To Developmental Drugs Inc?
Abigail Alliance For Better Access To Developmental Drugs Inc's revenue in 2022 was $57.
Who are the executives of Abigail Alliance For Better Access To Developmental Drugs Inc and what are their salaries?
Here are 2 key members and their salaries:
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
Where can I find the form 990EZ for Abigail Alliance For Better Access To Developmental Drugs Inc?
Abigail Alliance For Better Access To Developmental Drugs Inc's most recent form 990EZ was submitted in 2022 and can be accessed here.
Mission Statement of Abigail Alliance For Better Access To Developmental Drugs Inc
Abigail Alliance for Better Access to Developmental Drugs Inc, a dedicated nonprofit organization, has revised its mission for the years 2022 and 2023, with a significant shift towards cancer-related initiatives. Their primary focus now is on advocating for cancer patients and ensuring their access to developmental drugs. The organization aims to play a crucial role in facilitating the availability of these drugs, thereby potentially improving the outcomes for individuals battling cancer. By prioritizing cancer-related initiatives, Abigail Alliance for Better Access to Developmental Drugs Inc demonstrates its commitment to making a significant impact in the lives of those affected by cancer.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
October, 2024
Abigail Alliance For Better Access To Developmental Drugs Inc plays a significant role in advocating for patient access to developmental drugs, particularly in the field of cancer treatment. By focusing on barriers that prevent patients from obtaining potentially life-saving therapies, the organization seeks to ensure that individuals diagnosed with cancer have the opportunities to access innovative medications in a timely manner.
Their recent updates to mission objectives emphasize a concentrated effort on cancer-related initiatives, addressing both the advocacy for drug availability and the broader implications for patient care. This advocacy not only raises awareness about the urgent needs of patients facing life-threatening illnesses but also influences policy and regulatory frameworks that govern access to developmental therapies. Through their work, Abigail Alliance aims to create a more equitable healthcare landscape where patients can receive the emergent therapies they need to combat their diseases.
This information is meant to be a general summary of Abigail Alliance For Better Access To Developmental Drugs Inc. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Gross Receipts: $57
Assets and Liabilities:
- Total Assets: $7,917
- Total Liabilities: $0
- Net Assets: $7,917
Want to help this charity, for free? You can click here to learn more about Give Freely
Organization Details
Phone
(571) 228-6925Principal Officer
Prince Agarwal
Main Address
240 Chubb Ave Apt 229, Lyndhurst, NJ, 07071
NTEE Category
Code: G30 - Disease
If you are a representative of Abigail Alliance For Better Access To Developmental Drugs Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.